The Connecticut Bioscience Growth Council consists of representatives from CBIA member companies with biotech, pharmaceutical, and bioscience-related interests.
It was organized to better address the issues affecting this growing sector, especially the importance of strong intellectual property protection and the industry’s uniquely high R&D costs.
Working with CBIA staff, the council communicates to policymakers strategies to fuel industry job growth and timely introduction of new medicines, medical devices, and products developed and/or manufactured with the aid of bioscience.
The council meets regularly and interacts with the Connecticut General Assembly's Life Sciences Caucus and Connecticut's Congressional delegation.
Contact Paul Pescatello for more information.